Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 3
A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)
This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
Diabetic Macular EdemaDMEDiabetic Macular Edema (DME)
EyePoint Pharmaceuticals, Inc.NCT07449936
Phase 2
Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.
Diabetic macular edema is seen in the later stages of diabetic retinopathy with current conventional therapies targeting local vascular dysfunction. These ther…
Diabetic Macular Edema (DME)
University of Alabama at BirminghamNCT07457632